Utilization of Genetic Testing for RET Mutations in Patients with Medullary Thyroid Carcinoma: a Single-Center Experience
-
Published:2018-06-27
Issue:6
Volume:27
Page:1411-1416
-
ISSN:1059-7700
-
Container-title:Journal of Genetic Counseling
-
language:en
-
Short-container-title:J Genet Counsel
Author:
Parkhurst Emily, Calonico EliseORCID, Abboy Sridevi
Subject
Genetics (clinical)
Reference29 articles.
1. Ademi, Z., Watts, G. F., Pang, J., Sijbrands, E. J. G., van Bockxmeer, F. M., O’Leary, P., et al. (2014). Cascade screening based on genetic testing is cost-effective: evidence for the implementation of models of care for familial hypercholesterolemia. Journal of Clinical Lipidology, 8, 390–400. 2. American Thyroid Association Guidelines Task Force, Kloos, R. T., Evans, D. B., Francis, G. L., Gagel, R. F., Gharib, H., Moley, H., et al. (2009). Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid, 19, 565–612. 3. Bergant, D., Hocevar, M., Besic, N., Glavac, D., Korosec, B., & Caserman, S. (2006). Hereditary medullary thyroid cancer in Slovenia—genotype-phenotype correlations. Wiener Klinische Wochenschrift, 118, 411–416. 4. Chen, H., Sippel, R. S., O’Dorisio, M. S., Vinik, A. I., Lloyd, R. V., Pacak, K., et al. (2010). The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer. Pancreas, 39(6), 775–783. 5. Chen, Z., Kolor, K., Grosse, S. D., Rodriguez, J. L., Lynch, J. A., Green, R. F., et al. (2017). Trends in utilization and costs of BRCA testing among women aged 18-64 years in the United States, 2003-2014. Genetics in Medicine, 00, 1–7.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|